NCT00429780View on ClinicalTrials.gov

Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions

Healthy

Interventions

BIOLOGICAL

Alum-ALM + BCG

Alum-ALM + BCG 200 ug per injection

Trial Locations (1)

14166

Center for Research & Training in Skin Diseases & Leprosy, Tehran

All Listed Sponsors

collaborator

Pasteur Institute of Iran, Tehran, Iran

UNKNOWN

collaborator

Razi Vaccine and Serum Research Institute

OTHER

collaborator

Centre for Disease Control & Management, Ministry of Health & Medical Education

OTHER_GOV

lead

Tehran University of Medical Sciences

OTHER

NCT00429780 - Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0) | Biotech Hunter | Biotech Hunter